Research location
Belmont
Massachusetts, United States
Advertisement
Research activity in Belmont
Massachusetts, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 118 trials and 119 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Belmont
118 linked trials · page 1 of 3One-Day cTBS Over the PrecuneusNCT07758010 · 2026-09-08 · 1 site observation
RECRUITING
Synaptic Mechanisms of Continuous Theta Burst Stimulation in DepressionNCT07560878 · 2026-03-11 · 1 site observation
RECRUITING
A Study of Brenipatide in Adult Participants With SchizophreniaNCT07410507 · 2026-02-10 · 1 site observation
RECRUITING
Stress Dynamics and Familial Risk for Depression in Female AdolescentsNCT06816329 · 2025-10-15 · 1 site observation
RECRUITING
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)NCT07101094 · 2025-09-22 · 1 site observation
RECRUITING
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological ManipulationNCT05232032 · 2025-02-01 · 1 site observation
RECRUITING
Validation of a Novel Cerebellar-striatal Satiety Circuit in HumansNCT06105164 · 2024-12-05 · 1 site observation
RECRUITING
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)NCT06585787 · 2024-09-26 · 1 site observation
RECRUITING
Biomarkers to Enhance Early Schizophrenia TreatmentNCT06969755 · 2024-09-04 · 1 site observation
RECRUITING
Cerebellar Modulation of Cognition in PsychosisNCT06107764 · 2024-07-31 · 1 site observation
RECRUITING
Study of ALTO-101 in Patients With SchizophreniaNCT06502964 · 2024-06-11 · 1 site observation
RECRUITING
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial DysfunctionNCT06191965 · 2024-06-01 · 1 site observation
RECRUITING
Ketogenic and Nutritional Interventions for First Episode Bipolar DisorderNCT06221852 · 2024-03-12 · 1 site observation
RECRUITING
Enhanced Coordinated Specialty Care for Early PsychosisNCT06071858 · 2024-02-01 · 1 site observation
RECRUITING
Cerebellar TMS and Satiety in Prader-Willi SyndromeNCT05938543 · 2023-09-01 · 1 site observation
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)NCT05980949 · 2023-07-11 · 1 site observation
RECRUITING
Biomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesNCT06740383 · 2023-01-01 · 1 site observation
RECRUITING
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide RibosideNCT05245903 · 2022-05-31 · 1 site observation
RECRUITING
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major DepressionNCT05630963 · 2021-12-29 · 1 site observation
RECRUITING
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in SchizophreniaNCT05343598 · 2021-10-13 · 1 site observation
RECRUITING
Neural Correlates of Stress and Perceived Control in Adolescent DepressionNCT04788524 · 2021-04-23 · 1 site observation
RECRUITING
Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early PsychosisNCT07503093 · 2027-01-15 · 1 site observation
NOT_YET_RECRUITING
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101NCT07785102 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive DisorderNCT07593222 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient CareNCT07364825 · 2026-01-05 · 1 site observation
COMPLETED
Open Label Extension Study of NCT06221852NCT06558201 · 2024-08-28 · 1 site observation
ENROLLING_BY_INVITATION
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's DiseaseNCT06546995 · 2024-07-09 · 1 site observation
COMPLETED
PRISM Neurofeedback Training for MDD Anhedonic PatientsNCT05869708 · 2023-07-01 · 1 site observation
COMPLETED
SMART Trial to Predict Anhedonia Response to Antidepressant TreatmentNCT05537584 · 2022-09-30 · 1 site observation
COMPLETED
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot StudyNCT05380583 · 2022-05-19 · 1 site observation
COMPLETED
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's DementiaNCT04430517 · 2022-03-02 · 1 site observation
COMPLETED
ALTO-100 in MDD and/or PTSDNCT05117632 · 2021-12-20 · 1 site observation
COMPLETED
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)NCT03926520 · 2021-01-28 · 1 site observation
COMPLETED
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)NCT04325529 · 2021-01-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's DementiaNCT04075435 · 2021-01-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Families With Substance Use and Psychosis: A Pilot StudyNCT04284813 · 2020-09-24 · 1 site observation
COMPLETED
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant DepressionNCT04239963 · 2020-08-17 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205NCT04241068 · 2020-03-02 · 1 site observation
TERMINATED
Biomarkers of Response to Treatment With Frontal Cortex Stimulation for Anxious DepressionNCT03999736 · 2020-02-13 · 1 site observation
TERMINATED
Electrophysiological Correlates of Cognition in DepressionNCT03998748 · 2019-10-08 · 1 site observation
TERMINATED
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic DisordersNCT03943537 · 2019-10-01 · 1 site observation
COMPLETED
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseNCT03887455 · 2019-03-27 · 1 site observation
ACTIVE_NOT_RECRUITING
ERG Components in Schizophrenia and Bipolar Disorder Type INCT03788811 · 2018-07-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's DiseaseNCT03352557 · 2018-05-03 · 1 site observation
TERMINATED
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)NCT03367403 · 2017-12-18 · 1 site observation
COMPLETED
Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in DepressionNCT03031665 · 2017-10-01 · 1 site observation
COMPLETED
McLean and Genomind Prospective StudyNCT03113890 · 2017-09-22 · 1 site observation
COMPLETED
Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's DiseaseNCT02792257 · 2017-03-01 · 1 site observation
COMPLETED
Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease DementiaNCT03001557 · 2016-12-20 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.